Experience
Antares Pharma, Inc. v. Medac Pharma, Inc.
Antares Pharma, Inc.
Medac Pharma Inc.
Counsel for Antares successfully leading to institution of an IPR, and ultimately settlement of all IPR and litigation matters on a patent directed to the use of Otrexup® (subcutaneously injectable methotrexate) to treat autoimmune diseases.
Antares Pharma, Inc. v. Medac Pharma Inc., IPR2014-01091, PTAB, Judges Bonilla, Franklin, Scheiner